mRNA COVID-19 vaccines: science versus misinformation
RNA · 2026-06 · 32 (6) · 759-771
DOI: 10.1261/rna.080944.126 ↗Kurz gefasst
Fachartikel in der Zeitschrift RNA, online erschienen am 18.03.2026. Verfasst von Jeff Coller und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Alliance for mRNA Medicines, Washington, DC 20001, USA jmcoller@jhmi.edu. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The rapid development of COVID-19 vaccines as a result of Operation Warp Speed represented an extraordinary triumph of scientific innovation, with multiple vaccine platforms demonstrating remarkable efficacy in preventing severe disease, hospitalization, and death—ultimately saving millions of lives. The U.S. government, pharmaceutical companies, research institutions, and health agencies collaborated at an unprecedented scale to develop, test, and distribute vaccines, showcasing what coordinated medical innovation can accomplish. Vaccination programs successfully prevented catastrophic outcomes and enabled people to return to normal life during the crisis. COVID-19 vaccines continue to provide critical protection for vulnerable populations today, and the mRNA platforms developed have opened new possibilities for treating cancers and other diseases. Yet despite rigorous regulatory oversight and extensive clinical trial data, these vaccines have faced substantial misinformation campaigns that spread false claims about their safety and design. To address these misrepresentations and resultant public concerns, this document draws on rigorous scientific evidence to comprehensively examine the misconceptions surrounding mRNA technology, explaining how these vaccines work, their proven safety record, and their demonstrated benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Alliance for mRNA Medicines, Washington, DC 20001, USA jmcoller@jhmi.edu.
- RNA Innovation Center, Johns Hopkins University, Baltimore, Maryland 21218, USA.
- The Alliance for mRNA Medicines, Washington, DC 20001, USA.
- Replicate Bioscience, San Diego, California 92121, USA.
- Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01655, USA.
- Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology, Barcelona 08003, Spain.
Zitieren
APA
Coller, J., Geall, A., Duncan, R., Alspach, C., Ryder, S., Moore, M. J., & Gebauer, F. (2026). mRNA COVID-19 vaccines: science versus misinformation. RNA, 32(6), 759-771. https://doi.org/10.1261/rna.080944.126
Vancouver
Coller J, Geall A, Duncan R, Alspach C, Ryder S, Moore MJ, et al. mRNA COVID-19 vaccines: science versus misinformation. RNA. 2026;32(6):759-771. doi:10.1261/rna.080944.126
BibTeX
@article{Coller2026,
author = {Coller, Jeff and Geall, Andrew and Duncan, Roberta and Alspach, Clay and Ryder, Sean and Moore, Melissa J and Gebauer, Fátima},
title = {mRNA COVID-19 vaccines: science versus misinformation},
journal = {RNA},
year = {2026},
volume = {32},
number = {6},
pages = {759--771},
doi = {10.1261/rna.080944.126}
}
EUVIMED